Advanced Cholangiocarcinoma (Part 1)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Advanced Cholangiocarcinoma (Part 1) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

Not Yet RecruitingNot Applicable

NCT07164703

A Real-World Study of Precision Treatment for Advanced Cholangiocarcinoma Based on Molecular Subtyping

This is a multi-center, real-world study aiming to evaluate the efficacy and safety of precision treatment for advanced cholangiocarcinoma (CCA) with different…

China55 participantsStarted 2025-10-01

Treatment: Targeted drugs or immunotherapies for cholangiocarcinoma based on targetable gene mutations.

TerminatedPhase 1/2

NCT00959946

Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer

This is a research study in 2 parts assessing the following parameters of the combination of the study drug called bosutinib, and a drug called capecitabine: th…

United States, Australia +2 more32 participantsStarted 2009-09

Treatment: Bosutinib, Capecitabine